About This Statistic
This statistic represents the top asthma drugs in the United States, based on revenue between July 2011 and June 2012. In this period, the asthma drug Singulair generated around 4.9 billion U.S. dollars of revenues.
The Statistics Portal
Statistics and Studies from more than 18,000 Sources